Oxycodone News and Research

RSS
Long-term use of opioids increases risk of new-onset depression

Long-term use of opioids increases risk of new-onset depression

DURECT reports successful completion of DUR-928 Phase 1 study for acute use indications

DURECT reports successful completion of DUR-928 Phase 1 study for acute use indications

Crackdown on Florida's 'pill mills' reduces painkiller overdose deaths

Crackdown on Florida's 'pill mills' reduces painkiller overdose deaths

New data shows opioid overdose deaths hit record levels in 2014

New data shows opioid overdose deaths hit record levels in 2014

Egalet submits NDA for ARYMO ER (morphine sulfate) extended-release tablets

Egalet submits NDA for ARYMO ER (morphine sulfate) extended-release tablets

Egalet, Teva sign agreement to commercialize SPRIX Nasal Spray in Israel, Gaza and the West Bank

Egalet, Teva sign agreement to commercialize SPRIX Nasal Spray in Israel, Gaza and the West Bank

TSRI researchers awarded $1.6 million grant to advance preclinical studies of potential heroin vaccine

TSRI researchers awarded $1.6 million grant to advance preclinical studies of potential heroin vaccine

Medical researchers use social media to study harmful side effects of narcotics medication

Medical researchers use social media to study harmful side effects of narcotics medication

FDA approves Narcan nasal spray to prevent or reverse effects of opioid overdose

FDA approves Narcan nasal spray to prevent or reverse effects of opioid overdose

Prescription opioids overprescribed in some regions of British Columbia, UBC study finds

Prescription opioids overprescribed in some regions of British Columbia, UBC study finds

Study: Pediatric patients prescribed more opioid medication than necessary following surgery

Study: Pediatric patients prescribed more opioid medication than necessary following surgery

BDSI announces FDA approval of BUNAVAIL sNDA for manufacturing specification change

BDSI announces FDA approval of BUNAVAIL sNDA for manufacturing specification change

FDA accepts Braeburn's resubmission of Probuphine NDA for review

FDA accepts Braeburn's resubmission of Probuphine NDA for review

Study shows half of adolescents misuse their prescription drugs

Study shows half of adolescents misuse their prescription drugs

BioDelivery Sciences and Endo present Phase 2 data on buprenorphine HCl buccal film in patients with chronic pain

BioDelivery Sciences and Endo present Phase 2 data on buprenorphine HCl buccal film in patients with chronic pain

Egalet announces launch of OXAYDO (oxycodone HCI, USP) Tablets and IMPACT-Rx initiative

Egalet announces launch of OXAYDO (oxycodone HCI, USP) Tablets and IMPACT-Rx initiative

Egalet to present scientific data on SPRIX Nasal Spray at Painweek 2015

Egalet to present scientific data on SPRIX Nasal Spray at Painweek 2015

Researchers evaluate use of pharmacy-based naloxone education and distribution to fight opioid overdoses

Researchers evaluate use of pharmacy-based naloxone education and distribution to fight opioid overdoses

BDSI announces FDA approval of sNDA for new formulation of ONSOLIS (fentanyl buccal soluble film) CII

BDSI announces FDA approval of sNDA for new formulation of ONSOLIS (fentanyl buccal soluble film) CII

Egalet declares pricing of underwritten public offering of common stock

Egalet declares pricing of underwritten public offering of common stock